SPEARHEAD 2 Study in Subjects With Recurrent or Metastatic Head and Neck Cancer
a study on Head and Neck Cancer
Head and Neck Cancer Cell Therapy T-cell Therapy SPEAR T-Cell MAGE-A4 ADP-A2M4 Immuno-oncology Head and Neck Neoplasms Pembrolizumab ADP-A2M4 in combination with pembrolizumab.
Lead Scientist at UC Cancer
- Ezra Cohen, MD (ucsd)
Professor, Medicine. Authored (or co-authored) 190 research publications.
- accepting new patients
- Start Date
- Completion Date
- Phase 2
- Study Type
- Last Updated